FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jason White

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Living Beings

Rats

Activities & Behaviors

Motor Activity

Physiology

Procedures

Cross-Over Studies

Co-author Network

Publications

TOP 3
Andrea L Gordon; Olga V Lopatko; Vicki Pearson; Helen Stacey; Ann Fisk; Anna Woods; Jason M White
Patterns of symptom reporting during pregnancy comparing opioid maintained and control women.
Janet K Coller; Joel Colvill; Aaron L Farquharson; Heather M James; Jennifer R Michalakas; Jason M White; Andrew A Somogyi
Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
Eloise A Gelston; Heather M James; Olga V Lopatko; Helmut Schmidt; Janet K Coller; Jason M White; Andrew A Somogyi
Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jason White (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Andrea L Gordon; Olga V Lopatko; Vicki Pearson; Helen Stacey; Ann Fisk; Anna Woods; Jason M White
Patterns of symptom reporting during pregnancy comparing opioid maintained and control women.
Journal of addiction medicine 2012;6(4):258-64.
2012: Janet K Coller; Joel Colvill; Aaron L Farquharson; Heather M James; Jennifer R Michalakas; Jason M White; Andrew A Somogyi
Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
British journal of clinical pharmacology 2012;74(5):835-41.
2012: Eloise A Gelston; Heather M James; Olga V Lopatko; Helmut Schmidt; Janet K Coller; Jason M White; Andrew A Somogyi
Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.
British journal of clinical pharmacology 2012;73(5):786-94.
2012: Steven M Savvas; Andrew A Somogyi; Jason M White
The effect of methadone on emotional reactivity.
Addiction (Abingdon, England) 2012;107(2):388-92.
2012: Daniel T Barratt; Andrew Byrne; Janet K Coller; David J R Foster; Richard Hallinan; Jason M White; Andrew A Somogyi
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics.
Pharmacogenomics and personalized medicine 2012;5():53-62.
2012: Matthew J Dry; Aaron L Farquharson; Ted Nettelbeck; Nicholas R Burns; Jason M White
Dose-related effects of alcohol on cognitive functioning.
PloS one 2012;7(11):e50977.
2011: Janet K Coller; Carolyn Edmonds; Aaron L Farquharson; Marie Longo; Rinaldo Minniti; Andrew A Somogyi; Thomas Sullivan; Sharon Cahill; Jason M White
OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence.
Pharmacogenetics and genomics 2011;21(12):902-5.
2011: Chang Chen; Peter Felgate; Peter Harpas; Rodney J Irvine; Chris Kostakis; Jason M White
Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis.
Journal of studies on alcohol and drugs 2011;72(5):737-40.
2011: Rodney J Irvine; Emily J Jaehne; Chris Kostakis; Chang Chen; Peter Felgate; Jason M White
Population drug use in Australia: a wastewater analysis.
Forensic science international 2011;210(1-3):69-73.
2011: Kate M Morefield; Michael Keane; Peter Felgate; Jason M White; Rodney J Irvine
Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users.
Addiction (Abingdon, England) 2011;106(7):1293-300.
2011: J L Hay; Sophie F La Vincente; Andrew A Somogyi; C B Chapleo; Jason M White
Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects.
European journal of pain (London, England) 2011;15(3):293-8.
2010: Andrea L Gordon; Olga V Lopatko; Andrew A Somogyi; David J R Foster; Jason M White
(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy.
British journal of clinical pharmacology 2010;70(6):895-902.
2010: Justine N Whitham; Nicola J Spurrier; Michael G Sawyer; Peter Baghurst; John E Taplin; Jason M White; Andrea L Gordon
The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials.
Neurotoxicology and teratology 2010;32(2):280-8.
2010: Justin L Hay; Jahangir Kaboutari; Jason M White; Abdallah Salem; Rod Irvine
Model of methadone-induced hyperalgesia in rats and effect of memantine.
European journal of pharmacology 2010;626(2-3):229-33.
2010: Linda R Gowing; Robert Ali; Jason M White
Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal.
Cochrane database of systematic reviews (Online) 2010;(1):CD002022.
2009: Liang Liu; Mark Hutchinson; Jason M White; Andrew A Somogyi; Janet K Coller
Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence.
Pharmacogenetics and genomics 2009;19(11):869-76.
2009: Justin L Hay; Jason M White; Felix Bochner; Andrew A Somogyi; Tim J Semple; Bruce Rounsefell
Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients.
The journal of pain : official journal of the American Pain Society 2009;10(3):316-22.
2009: Linda R Gowing; Robert Ali; Jason M White
Opioid antagonists with minimal sedation for opioid withdrawal.
Cochrane database of systematic reviews (Online) 2009;(4):CD002021.
2009: Linda R Gowing; Robert Ali; Jason M White
Buprenorphine for the management of opioid withdrawal.
Cochrane database of systematic reviews (Online) 2009;(3):CD002025.
2009: Linda R Gowing; Michael Farrell; Robert Ali; Jason M White
Alpha2-adrenergic agonists for the management of opioid withdrawal.
Cochrane database of systematic reviews (Online) 2009;(2):CD002024.
2008: Andrew A Somogyi; Mie Larsen; Reza M Abadi; Jaroon Jittiwutikarn; Robert Ali; Jason M White
Flexible dosing of tincture of opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics.
British journal of clinical pharmacology 2008;66(5):640-7.
2008: Justin L Hay; Jason M White; Felix Bochner; Andrew A Somogyi
Antinociceptive effects of high-dose remifentanil in male methadone-maintained patients.
European journal of pain (London, England) 2008;12(7):926-33.
2008: Lisa N Yelland; Jaimi P Burns; D Noel Sims; Amy B Salter; Jason M White
Inter- and intra-subject variability in ethanol pharmacokinetic parameters: effects of testing interval and dose.
Forensic science international 2008;175(1):65-72.
2008: Sophie F La Vincente; Jason M White; Andrew A Somogyi; Felix Bochner; C B Chapleo
Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects.
Clinical pharmacology and therapeutics 2008;83(1):144-52.
2007: Jason M White; Olga V Lopatko
Opioid maintenance: a comparative review of pharmacological strategies.
Expert opinion on pharmacotherapy 2007;8(1):1-11.
2006: Timothy Mitchell; Jason M White; Andrew A Somogyi; Felix Bochner
Switching between methadone and morphine for maintenance treatment of opioid dependence: impact on pain sensitivity and mood status.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2006;15(4):311-5.
2006: Timothy Mitchell; Kyle R Dyer; David A L Newcombe; Andrew A Somogyi; Jason M White
Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients.
Addiction biology 2006;11(2):170-4.
2006: Peter Athanasos; Charlotte S Smith; Jason M White; Andrew A Somogyi; Felix Bochner; Walter Ling
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations.
Pain 2006;120(3):267-75.
2006: Rodney J Irvine; Michael Keane; Peter Felgate; Una D McCann; Paul D Callaghan; Jason M White
Plasma drug concentrations and physiological measures in 'dance party' participants.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(2):424-30.
2005: Julia Hanna; David J R Foster; Amy Salter; Andrew A Somogyi; Jason M White; Felix Bochner
Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects.
British journal of clinical pharmacology 2005;60(4):404-13.
2005: Catherine McGregor; Srisurapanont Manit; Jaroon Jittiwutikarn; Suchart Laobhripatr; Thirawat Wongtan; Jason M White
The nature, time course and severity of methamphetamine withdrawal.
Addiction (Abingdon, England) 2005;100(9):1320-9.
2004: Timothy Mitchell; Kyle R Dyer; David A L Newcombe; Amy Salter; Andrew A Somogyi; Felix Bochner; Jason M White
Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure.
British journal of clinical pharmacology 2004;58(6):609-17.
2004: Jaroon Jittiwutikarn; Robert Ali; Jason M White; Felix Bochner; Andrew A Somogyi; David J R Foster
Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre.
British journal of clinical pharmacology 2004;58(5):536-41.
2004: David A L Newcombe; Felix Bochner; Jason M White; Andrew A Somogyi
Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis.
Drug and alcohol dependence 2004;76(1):63-72.
2004: Jason M White
Pleasure into pain: the consequences of long-term opioid use.
Addictive behaviors 2004;29(7):1311-24.
2004: Timothy Mitchell; Jason M White; Andrew A Somogyi; Felix Bochner
Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence.
Addiction (Abingdon, England) 2004;99(8):940-5.
2004: David J R Foster; Andrew A Somogyi; Jason M White; Felix Bochner
Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients.
British journal of clinical pharmacology 2004;57(6):742-55.
2004: Sotiria Bexis; Benjamin D Phillis; Jennifer Ong; Jason M White; Rodney J Irvine
Baclofen prevents MDMA-induced rise in core body temperature in rats.
Drug and alcohol dependence 2004;74(1):89-96.
2004: Tanya Lewanowitsch; Jason M White; Rodney J Irvine
Use of radiotelemetry to evaluate respiratory depression produced by chronic methadone administration.
European journal of pharmacology 2004;484(2-3):303-10.
2003: Timothy Mitchell; Jason M White; Andrew A Somogyi; Felix Bochner
Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence.
Drug and alcohol dependence 2003;72(1):85-94.
2003: Olga V Lopatko; Jason M White; Alice Huber; Walter Ling
Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine.
Drug and alcohol dependence 2003;69(3):317-22.
2002: Catherine McGregor; Robert Ali; Jason M White; Peter Thomas; Linda R Gowing
A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months.
Drug and alcohol dependence 2002;68(1):5-14.
2002: Linda R Gowing; Robert L Ali; Jason M White
Which substitution pharmacotherapy is most effective in treating opioid dependence?
The Medical journal of Australia 2002;176(10):493-4.
2002: Jason M White; Catherine Danz; Joanne Kneebone; Sophie F La Vincente; David A L Newcombe; Robert L Ali
Relationship between LAAM-methadone preference and treatment outcomes.
Drug and alcohol dependence 2002;66(3):295-301.
2002: Susan J Porter; Andrew A Somogyi; Jason M White
In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
Addiction biology 2002;7(2):219-25.
2002: Lisa M Kaminskas; Rodney J Irvine; Paul D Callaghan; Jason M White; Paul Kirkbride
The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine.
Psychopharmacology 2002;160(2):155-60.
2002: Linda R Gowing; Michael Farrell; Robert L Ali; Jason M White
Alpha2-adrenergic agonists in opioid withdrawal.
Addiction (Abingdon, England) 2002;97(1):49-58.
2001: M Chew; Jason M White; Andrew A Somogyi; Felix Bochner; Rodney J Irvine
Precipitated withdrawal following codeine administration is dependent on CYP genotype.
European journal of pharmacology 2001;425(3):159-64.
2001: M Doverty; Andrew A Somogyi; Jason M White; Felix Bochner; C H Beare; Andrew Menelaou; Walter Ling
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine.
Pain 2001;93(2):155-63.
2001: Elizabeth Elliot; Jason M White
The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry.
Neuropharmacology 2001;40(5):717-21.
2001: Kyle R Dyer; Jason M White; David J R Foster; Felix Bochner; Andrew Menelaou; Andrew A Somogyi
The relationship between mood state and plasma methadone concentration in maintenance patients.
Journal of clinical psychopharmacology 2001;21(1):78-84.
2001: M Doverty; Jason M White; Andrew A Somogyi; Felix Bochner; R Ali; Walter Ling
Hyperalgesic responses in methadone maintenance patients.
Pain 2001;90(1-2):91-6.
2001: Benjamin D Phillis; Jennifer Ong; Jason M White; C Bonnielle
Modification of d-amphetamine-induced responses by baclofen in rats.
Psychopharmacology 2001;153(3):277-84.
2000: S J Porter; Andrew A Somogyi; Jason M White
Kinetics and inhibition of the formation of 6beta-naltrexol from naltrexone in human liver cytosol.
British journal of clinical pharmacology 2000;50(5):465-71.
2000: David J R Foster; Andrew A Somogyi; Kyle R Dyer; Jason M White; Felix Bochner
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.
British journal of clinical pharmacology 2000;50(5):427-40.
2000: Marie Longo; C E Hunter; R J Lokan; Jason M White; M A White
The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability.
Accident; analysis and prevention 2000;32(5):623-32.
2000: Marie Longo; C E Hunter; R J Lokan; Jason M White; M A White
The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part i: the prevalence of drug use in drive the drug-positive group.
Accident; analysis and prevention 2000;32(5):613-22.
2000: Lynette Daws; Rodney J Irvine; Paul D Callaghan; N P Toop; Jason M White; Felix Bochner
Differential behavioural and neurochemical effects of para-methoxyamphetamine and 3,4-methylenedioxymethamphetamine in the rat.
Progress in neuro-psychopharmacology & biological psychiatry 2000;24(6):955-77.
2000: Linda R Gowing; Robert L Ali; Jason M White
Systematic review processes and the management of opioid withdrawal.
Australian and New Zealand journal of public health 2000;24(4):427-31.
2000: Elizabeth Elliot; Jason M White
Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem.
Pharmacology, biochemistry, and behavior 2000;66(2):361-9.
2000: Elizabeth Elliot; Jason M White
Long-term abecarnil administration produces tolerance and withdrawal signs in the rat.
European journal of pharmacology 2000;394(2-3):237-45.
1999: Lynette Daws; Jason M White
Regulation of opioid receptors by opioid antagonists: implications for rapid opioid detoxification.
Addiction biology 1999;4(4):391-7.
1999: A Malpass; Jason M White; Rodney J Irvine; Andrew A Somogyi; Felix Bochner
Acute toxicity of 3,4-methylenedioxymethamphetamine (MDMA) in Sprague-Dawley and Dark Agouti rats.
Pharmacology, biochemistry, and behavior 1999;64(1):29-34.
1999: Jason M White; Rodney J Irvine
Future directions in opioid overdose.
Addiction (Abingdon, England) 1999;94(7):978-80.
1999: Jason M White; Rodney J Irvine
Mechanisms of fatal opioid overdose.
Addiction (Abingdon, England) 1999;94(7):961-72.
1999: Kyle R Dyer; David J R Foster; Jason M White; Andrew A Somogyi; Andrew Menelaou; Felix Bochner
Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships.
Clinical pharmacology and therapeutics 1999;65(6):685-94.
1997: Kyle R Dyer; Jason M White
Patterns of symptom complaints in methadone maintenance patients.
Addiction (Abingdon, England) 1997;92(11):1445-55.
1997: Rodney J Irvine; Jason M White
The effects of central and peripheral angiotensin on hypertension and nociception in rats.
Pharmacology, biochemistry, and behavior 1997;57(1-2):37-41.
1996: Jason M White; C F Ryan
Pharmacological properties of ketamine.
Drug and alcohol review 1996;15(2):145-55.
1996: Jason M White; C F Ryan; R L Ali
Improvements in retention rates and changes in client group with methadone maintenance streaming.
Drug and alcohol review 1996;15(1):83-8.
1996: C F Ryan; Jason M White
Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire.
Addiction (Abingdon, England) 1996;91(1):39-45.
1995: R E Humeniuk; Jennifer Ong; David I B Kerr; Jason M White
Characterization of GABAB ligands in vivo.
General pharmacology 1995;26(2):417-24.
1995: Rodney J Irvine; Jason M White; Richard J Head
The renin angiotensin system and nociception in spontaneously hypertensive rats.
Life sciences 1995;56(13):1073-8.
1994: R E Humeniuk; Jason M White; Jennifer Ong
The effects of GABAB ligands on alcohol withdrawal in mice.
Pharmacology, biochemistry, and behavior 1994;49(3):561-6.
1994: Jason M White; C R Frewin; M Kaur; S Flavel; C McGregor
Twenty-four hour ambulatory monitoring of tremor, sweating, skin temperature and locomotor activity in the alcohol withdrawal syndrome.
Clinical autonomic research : official journal of the Clinical Autonomic Research Society 1994;4(1-2):15-8.
1993: R E Humeniuk; Jason M White; Jennifer Ong
The role of GABAB receptors in mediating the stimulatory effects of ethanol in mice.
Psychopharmacology 1993;111(2):219-24.